Cardiac surgery in end stage renal disease patients

WANG Xin,ZUO Li
DOI: https://doi.org/10.3969/j.issn.1671-4091.2011.12.003
2011-01-01
Abstract:Objectives To investigate the clinical characteristics and outcome of end-stage renal disease (ESRD) patients undergoing cardiac surgery,and to explore the optimal protocol for peri-operative renal replacement therapy.Methods A single-center retrospective analysis was conducted in dialysis patients who were managed with coronary artery bypass grafting (CABG) and/or cardiac valve replacement (VR) during the period between September,2004 and January,2011.Results Sixteen patients who met our inclusion criteria were studied.CABG was performed in 8 patients,VR in 5 patients,and CABG+ VR in 3 patients.Extended low-efficiency hemodiafiltration commenced 6.7±5.1 hours after operation.Every hemodiafiltration session lasted 9.71±3.75 hours and consumed 33.0±11.6 liters of replacement fluid.The average hemodiafiltration sessions were 4.83±2.95 times for a patient before they were converted to regular hemodialysis or hemodiafiltration.The in-hospital mortality was 25% (4/16),and the causes of death were peri-operative myocardial infarction (one patient),pericardial temponade (one patient) and low output syndrome (2 patients).Survival patients were followed up for 33 (3~65) months,and during that period 3 patients died of hepatic carcinoma,cerebral hemorrhage or heart failure.Conclusions Dialysis-dependent patients undergoing cardiac surgery could achieve better successful rate with long-term survival when intensive peri-operative renal replacement therapy was used.In-hospital mortality was high in elder patients managed with CABG and VR simultaneously.
What problem does this paper attempt to address?